GERI IAMES: Open Payments
NPI 1144792961 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 14 payments from 13 companies in 2025. Trend: 2023 $186 · 2024 $957 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $52 |
| PFIZER INC. | 1 | $29 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $28 |
| Iovance Biotherapeutics, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| BeiGene USA, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: TEVIMBRA, IBRANCE, Itovebi, MONJUVI, CARVYKTI, Amtagvi, Trodelvy, JAKAFI.
Industry payments across MD — which companies pay providers there.
